Acadia Pharmaceuticals Inc. (ACAD) P/E ratio

P/E ratio today
8.6×

Acadia Pharmaceuticals Inc. (ACAD) trades at 8.6× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 11.6×. That is 13.9% lower than the 13.5× of fiscal 2024. Figures as of 18 Nov 2026, 06:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
8.6×
P/E ratio, fiscal 2025
11.6×
Change on fiscal 2024
−13.9%
Highest on record
13.5×fiscal 2024
Lowest on record
3.1×fiscal 2010
Fiscal years on record
32010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Acadia Pharmaceuticals Inc. P/E ratio, in more detail

Today's figure is 25.6% below the fiscal 2025 year-end.

Across the 3 fiscal year-ends on record (2010–2025), the highest was 13.5× in fiscal 2024 and the lowest 3.1× in fiscal 2010. Today's P/E ratio is higher than at 33% of the 3 fiscal year-ends on record; their median is 11.6×.

History · 3 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Acadia Pharmaceuticals Inc. P/E ratio, year by year

Acadia Pharmaceuticals Inc. (ACAD) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today8.6×—$18.32—
202511.6× 13.9% down$26.71$2.30
202413.5×—$18.35$1.36
2023——$31.31-$0.37
2022——$15.92-$1.34
2021——$23.34-$1.05
2020——$53.46-$1.79
2019——$42.78—
2018——$16.17—
2017——$30.11—
2016——$28.84—
2015——$35.65—
2014——$31.75—
2013——$24.99—
2012——$4.65-$0.38
2011——$1.08-$0.44
20103.1×—$1.20$0.39
2009——$1.32-$1.20

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on ACAD

Acadia Pharmaceuticals Inc., figure by figure

Acadia Pharmaceuticals Inc. (ACAD) overview: price, valuation and scorecard

Acadia Pharmaceuticals Inc. P/E ratio: questions and answers

What is Acadia Pharmaceuticals Inc.'s P/E ratio?

Acadia Pharmaceuticals Inc. (ACAD) trades at 8.6× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 11.6×. That is 13.9% lower than the 13.5× of fiscal 2024.

Is Acadia Pharmaceuticals Inc.'s P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 33% of the 3 fiscal year-ends on record; their median is 11.6×.

What are the highest and lowest P/E ratio figures on record for Acadia Pharmaceuticals Inc.?

Across the 3 fiscal year-ends on record (2010–2025), the highest was 13.5× in fiscal 2024 and the lowest 3.1× in fiscal 2010.

How is Acadia Pharmaceuticals Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Acadia Pharmaceuticals Inc. (ACAD) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ACAD/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.